SSA
PLSE icon

Schonfeld Strategic Advisors’s Pulse Biosciences PLSE Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,300
Closed -$40K – 3120
2022
Q2 		$40K Buy
+26,300
New +$66.1K ﹤0.01% 2248

Other funds holding PLSE

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schonfeld Strategic Advisors's PLSE Position: Q3 2022 in Review

Schonfeld Strategic Advisors sold out of Pulse Biosciences (PLSE) in Q3 2022, closing a stake of 26,300 shares — an estimated $40K sold.

Schonfeld Strategic Advisors first reported a position in PLSE in Q2 2022 and held it in 1 quarter. The position peaked at $40K in Q2 2022. 31 funds tracked by Wall St. Rank hold PLSE as of Q3 2022.

  • Schonfeld Strategic Advisors reported no remaining Pulse Biosciences position as of Q3 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 26,300 Pulse Biosciences shares in Q3 2022, an estimated $40K.
  • Schonfeld Strategic Advisors first reported a position in Pulse Biosciences in Q2 2022 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Pulse Biosciences position peaked at $40K in Q2 2022.
  • 31 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.